M20Genomics
Founded 2021 · 11 employees on LinkedIn · 1 known investors
M20 Genomics develops single-cell and spatial technologies, offering the VITA platform built on its M20 Seq technology for single-cell transcriptome analysis across multiple sample types and species. It serves life science researchers with full transcriptome coverage and gene detection for scientific research.
Investors · 1
Frequently asked questions
- What does M20Genomics do?
- M20 Genomics develops single-cell and spatial technologies, offering the VITA platform built on its M20 Seq technology for single-cell transcriptome analysis across multiple sample types and species. It serves life science researchers with full transcriptome coverage and gene detection for scientific research.
- Who are M20Genomics's investors?
- M20Genomics's investors include Qiming Venture Partners.